Tagged with SDG 3 – Good Health and Well Being

Hope is on the horizon for sick children requiring intravenous canulation to administer medication

An often-overlooked allergic condition, eosinophilic esophagitis or EoE, is at the centre of new research investigating whether a natural seaweed product may reduce the occurrence of symptoms.

A project designed to help screen children and adolescents at risk of Fetal Alcohol Spectrum Disorder (FASD) has been awarded a National Health and Medical Research Council Partnership Grant worth $1.49 million.

A pilot smell clinic has commenced at Griffith’s Gold Coast campus in a bid to gather more data on how microorganisms within the nose can contribute to Alzheimer’s disease.

Griffith University researchers are on the brink of a technological breakthrough in vaccine development with a possible new vaccine modality.

Calls for more study to be conducted into how microorganisms contribute to the onset and progression of Alzheimer’s disease.

The development of a world-first intravenous (IV) Passport has caught the world’s attention with 20 countries downloading the application and an award from the consumer-led Australian Patients Association.